| Literature DB >> 20485326 |
Annabel Whibley1, Jill Urquhart, Jonathan Dore, Lionel Willatt, Georgina Parkin, Lorraine Gaunt, Graeme Black, Dian Donnai, F Lucy Raymond.
Abstract
Monoamine oxidases (MAO-A and MAO-B) have a key role in the degradation of amine neurotransmitters, such as dopamine, norepinephrine and serotonin. We identified an inherited 240 kb deletion on Xp11.3-p11.4, which encompasses both monoamine oxidase genes but, unlike other published reports, does not affect the adjacent Norrie disease gene (NDP). The brothers who inherited the deletion, and thus have no monoamine oxidase function, presented with severe developmental delay, intermittent hypotonia and stereotypical hand movements. The clinical features accord with published reports of larger microdeletions and selective MAO-A and MAO-B deficiencies in humans and mouse models and suggest considerable functional compensation between MAO-A and MAO-B under normal conditions.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20485326 PMCID: PMC2987451 DOI: 10.1038/ejhg.2010.41
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246